Wuhan, China · Founded 2022 · Privately Held (backing)
Developer of biopharmaceutical development and production systems designed for gene therapy and vaccine research purposes. Genevoyager is based in Wuhan, China and was founded in 2022. It has raised $27.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$27.9M
Last round
—
Team — not yet on record
No current team members for Genevoyager are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genevoyager with a free account
·Watch Genevoyager: the Monday email on marks, rounds and moves
